Industry: Medical Care
Published Date: 2025-01-16
Pages: 95 Pages
Report ld: 3471428
Request Sample
Customized Report
In-Vitro Diagnostics Market Size(US$)

CAGR 2025-2031
4.4%
Market Size,2031
USD 94,510
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for In-Vitro Diagnostics was valued at US$ 70210 million in the year 2024 and is projected to reach a revised size of US$ 94510 million by 2031, growing at a CAGR of 4.4% during the forecast period.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global In-Vitro Diagnostics Growth Trends by Region
2.2.1 Global In-Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In-Vitro Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 In-Vitro Diagnostics Market Dynamics
2.3.1 In-Vitro Diagnostics Industry Trends
2.3.2 In-Vitro Diagnostics Market Drivers
2.3.3 In-Vitro Diagnostics Market Challenges
2.3.4 In-Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2020-2025)
3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In-Vitro Diagnostics Revenue
3.4 Global In-Vitro Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2024
3.5 Global Key Players of In-Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of In-Vitro Diagnostics, Product and Application
3.7 Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
5 In-Vitro Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In-Vitro Diagnostics Market Size (2020-2031)
6.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In-Vitro Diagnostics Market Size by Country (2020-2025)
6.4 North America In-Vitro Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Diagnostics Market Size (2020-2031)
7.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In-Vitro Diagnostics Market Size by Country (2020-2025)
7.4 Europe In-Vitro Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Diagnostics Market Size (2020-2031)
9.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In-Vitro Diagnostics Market Size by Country (2020-2025)
9.4 Latin America In-Vitro Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche In-Vitro Diagnostics Introduction
11.1.4 Roche Revenue in In-Vitro Diagnostics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens In-Vitro Diagnostics Introduction
11.2.4 Siemens Revenue in In-Vitro Diagnostics Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott In-Vitro Diagnostics Introduction
11.3.4 Abbott Revenue in In-Vitro Diagnostics Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher In-Vitro Diagnostics Introduction
11.4.4 Danaher Revenue in In-Vitro Diagnostics Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Details
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher In-Vitro Diagnostics Introduction
11.5.4 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2020-2025)
11.5.5 Thermo Fisher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Details
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux In-Vitro Diagnostics Introduction
11.6.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2020-2025)
11.6.5 BioMerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad In-Vitro Diagnostics Introduction
11.7.4 Bio-Rad Revenue in In-Vitro Diagnostics Business (2020-2025)
11.7.5 Bio-Rad Recent Development
11.8 BD
11.8.1 BD Company Details
11.8.2 BD Business Overview
11.8.3 BD In-Vitro Diagnostics Introduction
11.8.4 BD Revenue in In-Vitro Diagnostics Business (2020-2025)
11.8.5 BD Recent Development
11.9 JNJ
11.9.1 JNJ Company Details
11.9.2 JNJ Business Overview
11.9.3 JNJ In-Vitro Diagnostics Introduction
11.9.4 JNJ Revenue in In-Vitro Diagnostics Business (2020-2025)
11.9.5 JNJ Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-Vitro Diagnostics Introduction
11.10.4 Sysmex Revenue in In-Vitro Diagnostics Business (2020-2025)
11.10.5 Sysmex Recent Development
11.11 KHB
11.11.1 KHB Company Details
11.11.2 KHB Business Overview
11.11.3 KHB In-Vitro Diagnostics Introduction
11.11.4 KHB Revenue in In-Vitro Diagnostics Business (2020-2025)
11.11.5 KHB Recent Development
11.12 DaAn Gene
11.12.1 DaAn Gene Company Details
11.12.2 DaAn Gene Business Overview
11.12.3 DaAn Gene In-Vitro Diagnostics Introduction
11.12.4 DaAn Gene Revenue in In-Vitro Diagnostics Business (2020-2025)
11.12.5 DaAn Gene Recent Development
11.13 Leadman
11.13.1 Leadman Company Details
11.13.2 Leadman Business Overview
11.13.3 Leadman In-Vitro Diagnostics Introduction
11.13.4 Leadman Revenue in In-Vitro Diagnostics Business (2020-2025)
11.13.5 Leadman Recent Development
11.14 BioSino
11.14.1 BioSino Company Details
11.14.2 BioSino Business Overview
11.14.3 BioSino In-Vitro Diagnostics Introduction
11.14.4 BioSino Revenue in In-Vitro Diagnostics Business (2020-2025)
11.14.5 BioSino Recent Development
11.15 BSBE
11.15.1 BSBE Company Details
11.15.2 BSBE Business Overview
11.15.3 BSBE In-Vitro Diagnostics Introduction
11.15.4 BSBE Revenue in In-Vitro Diagnostics Business (2020-2025)
11.15.5 BSBE Recent Development
11.16 Maccura
11.16.1 Maccura Company Details
11.16.2 Maccura Business Overview
11.16.3 Maccura In-Vitro Diagnostics Introduction
11.16.4 Maccura Revenue in In-Vitro Diagnostics Business (2020-2025)
11.16.5 Maccura Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global In-Vitro Diagnostics market is projected to grow from US$ 86860 million in 2025 to US$ 114701 million by 2032, at a CAGR of 4.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-12
Pages: 146
USD 4900.00
(Single User License)
The global In-Vitro Diagnostics market size was US$ 86860 million in 2025 and is forecast to reach a readjusted size of US$ 114701 million by 2032 with a CAGR of 4.1% during the forecast period 2026-2032.
Published Date: 2026-07-12
Pages: 139
USD 4250.00
(Single User License)
The global In-Vitro Diagnostics market was valued at US$ 86860 million in 2025 and is anticipated to reach US$ 114701 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published Date: 2026-07-12
Pages: 134
USD 2900.00
(Single User License)
The global market for In-Vitro Diagnostics was estimated to be worth US$ 86860 million in 2025 and is projected to reach US$ 114701 million, growing at a CAGR of 4.1% from 2026 to 2032.
Published Date: 2026-07-12
Pages: 124
USD 3950.00
(Single User License)
The global In-Vitro Diagnostics market is projected to grow from US$ 70210 million in 2024 to US$ 94510 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
In 2024, the global market size of In-Vitro Diagnostics was estimated to be worth US$ 70210 million and is forecast to reach approximately US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 152
USD 5900.00
(Single User License)
The global In-Vitro Diagnostics market size was US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
The global market for In-Vitro Diagnostics was estimated to be worth US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 122
USD 3950.00
(Single User License)
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
Published Date: 2024-04-17
Pages: 190
USD 5600.00
(Single User License)
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
The global In-Vitro Diagnostics market is projected to grow from US$ 86860 million in 2025 to US$ 114701 million by 2032, at a CAGR of 4.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-12
Pages: 146
The global In-Vitro Diagnostics market size was US$ 86860 million in 2025 and is forecast to reach a readjusted size of US$ 114701 million by 2032 with a CAGR of 4.1% during the forecast period 2026-2032.
Published: 2026-07-12
Pages: 139
The global In-Vitro Diagnostics market was valued at US$ 86860 million in 2025 and is anticipated to reach US$ 114701 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published: 2026-07-12
Pages: 134
The global market for In-Vitro Diagnostics was estimated to be worth US$ 86860 million in 2025 and is projected to reach US$ 114701 million, growing at a CAGR of 4.1% from 2026 to 2032.
Published: 2026-07-12
Pages: 124
The global In-Vitro Diagnostics market is projected to grow from US$ 70210 million in 2024 to US$ 94510 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 147
In 2024, the global market size of In-Vitro Diagnostics was estimated to be worth US$ 70210 million and is forecast to reach approximately US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 152
The global In-Vitro Diagnostics market size was US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
The global market for In-Vitro Diagnostics was estimated to be worth US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 122
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
Published: 2024-04-17
Pages: 190
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
Published: 2024-04-16
Pages: 186
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now